Release Date: 29/07/14 14:59 Summary: Activity Report & Appendix 4C Price Sensitive: Yes Download Document 155.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%